Company:  ENZON PHARMACEUTICALS INC (ENZN)
Form Type:  10-K
Filing Date:  3/9/2009 
CIK:  0000727510 
Address:  685 ROUTE 202/206 
City, State, Zip:  BRIDGEWATER, New Jersey 08807 
Telephone:  908 541 8671 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$9.04   		Change: 
0.04 (0.44%)  
Trade Time: 
04:00 PM EST   		Market Cap: 
$411.36M
Description of Business
Register for a Free Trial and access this filing in:     
  FORM 10-K
    PART I
      ITEM 1. BUSINESS
      Item 1A. Risk Factors
      Item 1B. Unresolved Staff Comments.
      Item 2. Properties
      Item 3. Legal Proceedings
      Item 4. Submission of Matters to a Vote of Security Holders
    PART II
      Item 5. Market for the Registrant's Common Equity, Related ...
      Item 6. Selected Financial Data
      Item 7. Management's Discussion and Analysis of Financial ...
        Results of Operations
        Liquidity and Capital Resources
      Item 7A. Quantitative and Qualitative Disclosures About ...
      Item 8. Financial Statements and Supplementary Data
      Item 9. Changes in and Disagreements with Accountants on ...
      Item 9A. Controls and Procedures
      Item 9B. Other Information
    PART III
    PART IV
      Item 15. Exhibits and Financial Statement Schedules.
    SIGNATURES
    Report of Independent Registered Public Accounting Firm
    BALANCE SHEET
    INCOME STATEMENT
    STOCKHOLDERS EQUITY
    CASH FLOW
    Notes to Consolidated Financial Statements
    VALUATION AND QUALIFYING ACCOUNTS
  EXHIBIT 10.31
  EXHIBIT 10.32
  EXHIBIT 10.33
  EXHIBIT 10.34
  EXHIBIT 10.35
  EXHIBIT 10.36
  EXHIBIT 10.37
  EXHIBIT 10.38
  EXHIBIT 12.1
  EXHIBIT 21.1
    SUBSIDIARIES
  EXHIBIT 23
    Consent of Independent Registered Public Accounting Firm
  EXHIBIT 31.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 31.2
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.1
    CERTIFICATION PURSUANT
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO
BROKERAGE PARTNERS
© 1995-2010 EDGAR Online, Inc. All rights reserved • NASDAQ: EDGR • Solutions for Corporations • Terms of Use • Privacy Statement